• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD EVOLUTION® COLONIC CONTROLLED-RELEASE STENT - UNCOVERED; MQR STENT, COLONIC METALLIC EXPANDABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD EVOLUTION® COLONIC CONTROLLED-RELEASE STENT - UNCOVERED; MQR STENT, COLONIC METALLIC EXPANDABLE Back to Search Results
Catalog Number UNKNOWN
Device Problem Off-Label Use (1494)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/21/2022
Event Type  malfunction  
Event Description
Zhang et al 2022 - safety and feasibility of neoadjuvant chemotherapy as a surgical bridge for acute left-sided malignant colorectal obstruction: a retrospective study.Depending on the location of obstructive lesion and presence of edematous bowels, left colectomy, anterior resection, low anterior resection, subtotal colectomy, abdominoperineal resection, and hartmann operation were performed by well-experienced colorectal surgeons in our single center.All sems placements were performed by well-experienced endoscopists using a wallflex colonic stent (boston scientific) or evolution colonic stent (cook ireland limited).The placement of sems includes interventional placement and endoscopic placement.For interventional placement, the patient was placed on the dsa operating bed supine, the perineum was routinely sterilized and draped, a 5f-dav catheter was placed through the anus, and the catheter-guided angiography showed the site of lesion obstruction, and a guide wire was inserted through the catheter.After reaching the distal end, transcatheter angiography showed obvious expansion and gas accumulation in the obstructed part of the lesion.A rigid guide wire was placed through the catheter to the lesion obstruction site, and the obstruction site and length were determined again.Endoscopic sems implantation: intravenous injection of midazolam, phloroglucinol and dezocine, observation of the guide wire placed in the stenotic site under dsa, and the smooth passage of the guide wire.In the stenotic part, a sems was introduced under direct vision.This complaint was opened to capture use of interventional stent placement (without endoscope) was off-label.As per ifu0052-11 that accompanies this device "introduce delivery system in short increments over wire guide, into accessory channel, until it is endoscopically visualised exciting the scope." no adverse effects noted in the literature paper as a result of the off label use.
 
Manufacturer Narrative
Pma/510(k) #k163468.Investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
 
Manufacturer Narrative
Pma/510(k) #k163468.Supplemental cancellation report is being submitted due to this complaint being cancelled.Additional clinical input received on 11-feb-2023 confirmed the use of interventional stent placement (without endoscope) was user error and not off-label use as per the initial assessment.As per ifu0052 that accompanies this device "introduce delivery system in short increments over wire guide, into accessory channel, until it is endoscopically visualised exciting the scope." complaint file is being cancelled as (b)(4)/mdr ref #3001845648-2023-00032 is already opened to capture user error noted in this literature paper.(b)(4)/mdr ref #3001845648-2023-00032 will be updated to include details of this complaint.
 
Event Description
Supplemental cancellation report is being submitted due to this complaint file being cancelled.Additional clinical input received on 11-feb-2023 confirmed the use of interventional stent placement (without endoscope) was user error and not off-label use as per the initial assessment.As per ifu0052 that accompanies this device "introduce delivery system in short increments over wire guide, into accessory channel, until it is endoscopically visualised exciting the scope." complaint file is being cancelled as (b)(4) /mdr ref #3001845648-2023-00032 is already opened to capture user error noted in this literature paper.(b)(4) /mdr ref #3001845648-2023-00032 will be updated to include details of this complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUTION® COLONIC CONTROLLED-RELEASE STENT - UNCOVERED
Type of Device
MQR STENT, COLONIC METALLIC EXPANDABLE
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer (Section G)
COOK IRELAND LTD
o halloran road
national technology park
limerick
Manufacturer Contact
sinead o'leary
o halloran road
national technology park
limerick 
MDR Report Key16182663
MDR Text Key309323540
Report Number3001845648-2023-00031
Device Sequence Number1
Product Code MQR
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date07/21/2022
Event Location Hospital
Initial Date Manufacturer Received 12/19/2022
Initial Date FDA Received01/17/2023
Supplement Dates Manufacturer Received12/19/2022
Supplement Dates FDA Received03/09/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age56 YR
Patient SexMale
-
-